)
Edge14 Nov 2025
Ball: The King of Cans
From a 19th-century glass-jar legacy to a global plant network, Ball is now a pure-play aluminum can partner to the world's biggest beverage brands.
Teva Pharmaceutical Industries (TEVA) investor relations material
Teva Pharmaceutical Industries UBS Global Healthcare Conference 2025 summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.UBS Global Healthcare Conference 2025 summary10 Nov, 2025
Strategic transformation and growth
Pivot to growth strategy implemented nearly three years ago, focusing on returning, accelerating, and maintaining growth.
Achieved 11 consecutive quarters of growth, with Q3 marking a shift to accelerated growth.
Innovative business grew 33% in Q3, surpassing $800 million in sales, with key products Austedo, Ajovy, and UZEDY showing strong double-digit growth.
Gross margin improved from 48% in Q1 2023 to a range of 40%-55% due to portfolio shift and operational efficiencies.
Company now positions itself as a biopharma leader with a robust generics and innovative pipeline.
Product performance and commercial strategy
Austedo's 38% Q3 growth driven by improved patient journey management, titration support, and transition to XR formulation.
Maintains disciplined approach to value and access, preparing for increasingly challenging payer environments.
UZEDY's uptake attributed to product profile advantages and disciplined pricing, avoiding excessive discounting to preserve long-term value.
Olanzapine LAI filing planned for this quarter, with launch targeted for the second half of next year.
Schizophrenia franchise expected to reach $1.5-$2 billion, with Austedo targeting $2.5-$3 billion.
Pipeline and innovation
Duvakitug advanced rapidly from phase two to phase three for UC and CD, with additional indications under consideration.
DARI (dual action rescue inhaler) on track for full recruitment by year-end, aiming for 2027 launch with pediatric indication as a differentiator.
Emphasis on disciplined, value-driven launches and deep understanding of patient journeys.
Teva's capital allocation strategy
UZEDY launch: value vs. volume strategy
Generics/biosimilars strategy post-Revlimid
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Teva Pharmaceutical Industries earnings date
Jefferies London Healthcare Conference 202518 Nov, 2025
Next Teva Pharmaceutical Industries earnings date
Jefferies London Healthcare Conference 202518 Nov, 2025
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets and distributes generic medicines and a portfolio of specialty medicines worldwide. It operates in two segments, Generic Medicines and Specialty Medicines. The company offers various APIs and molecules for the treatment of various disorders in a range of therapeutic areas, including CNS, oncology, respiratory, cardiology and other specialty areas. The company was founded in 1901 and is headquartered in Tel Aviv-Yafo, Israel.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage